HIV transmission rates drop in NSW and Albury will benefit from HIV prevention study extension

The latest HIV figures out of NSW point to progress towards the state’s goal of eliminating transmission by 2020.

Last year, 317 residents were notified with HIV – the lowest annual count in more than five years – despite a 21 percent jump in the number of tests conducted in public sexual health clinics.

It comes as the Albury Public Health Unit approaches a year of facilitating the EPIC Study, which gives at-risk residents access to medication called PrEP proven to prevent HIV transmission.

Sexual health clinical nurse consultant Alison Kincaid said the trial had received significant interest and was now being extended by two years.

“We’re still getting inquiries and continuing to enroll people who meet the criteria of being at a high risk of HIV,” she said.

“We’ve identified people that maybe wouldn’t have had a test before, and they’re hearing about the EPIC study and being proactive to take care of their sexual health.

“It’s been extended and we’re up-scaling the number of people on the study to prevent them getting HIV.”

Ms Kincaid said NSW was on its way to ending transmission.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below